Highlights Qiagen N.V.

Equities

QGEN

NL0015001WM6

Biotechnology & Medical Research

Market Closed - Nyse Other stock markets 04:00:02 2024-12-09 pm EST			5-day change	1st Jan Change
44.32 ^USD	+2.07%		+1.53%	-1.01%

Dec. 05	Qiagen Reports Over 1,000 Placements of EZ2 Connect Instrument Globally	MT
Dec. 05	Qiagen N.V. Presents at 7th Annual Evercore ISI HealthCONx Healthcare Conference, Dec-05-2024 10:50 AM

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Qiagen Reports Over 1,000 Placements of EZ2 Connect Instrument Globally	Dec. 05	MT
Qiagen Seeks Bolt-On Acquisitions	Dec. 04	CI
Qiagen Plans to Open New Facility in Spain in 2026	Nov. 29	MT
QIAGEN Launches Novel Tools for Customizing Digital PCR Assays and NGS Panels for Microbial Analysis	Nov. 27	CI
Qiagen Partners With McGill University for Microbiome Research	Nov. 13	MT
Qiagen, McGill University Enter Partnership Deal for Microbiome Research Development	Nov. 13	MT
Qiagen Collaborates with McGill University to Advance Microbiome Research	Nov. 12	CI
QIAGEN : Markets hailed the Q3 beat + the profitability upgrade	Nov. 07
Qiagen Q3 Adjusted Earnings, Revenue Increase; Raises 2024 Adjusted Earnings Guidance	Nov. 07	MT
Qiagen N.V. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	Nov. 06	CI
Diagnostics firm Qiagen reports rise in third-quarter revenue	Nov. 06	RE
Qiagen N.V. Reaffirms Earnings Guidance for the Full Year 2024	Nov. 06	CI
Qiagen Secures US FDA Nod for Meningitis, Encephalitis Panel	Nov. 04	MT
QIAGEN Receives FDA Clearance of QIAstat-Dx Meningitis/Encephalitis Panel to Support Emergency Diagnostics	Nov. 04	CI
QIAGEN Receives FDA Clearance for QIAstat-Dx Mini Panel to Improve Precision in Outpatient Respiratory Treatment	Oct. 29	CI
HSBC Downgrades QIAGEN to Hold From Buy, Price Target is $49	Oct. 17	MT
QIAGEN Expands Automated Liquid Biopsy Portfolio to Enhance Oncology, Prenatal Care and Organ Transplant Applications	Oct. 10	CI
QIAGEN N.V. Launches QIAcuityDx Digital PCR System for Clinical Testing in Oncology	Sep. 30	CI
Qiagen Gets European Certification for Syndromic Testing Systems	Sep. 26	MT
Qiagen Names Bode Technology as Exclusive Global Commercial Partner for GEDmatch PRO	Sep. 24	MT
Qiagen Launches 100 New Assays for QIAcuity Platform	Sep. 19	MT
QIAGEN expands QIAcuity digital PCR offering with over new 100 assays via GeneGlobe platform	Sep. 18	CI
Qiagen, Bio-Manguinhos/Fiocruz Launch Malaria Detection Test in Brazil	Sep. 13	MT
Qiagen Expands Partnership with Bio-Manguinhos/Fiocruz for Malaria Screening	Sep. 12	MT
QIAGEN N.V. and Bio-Manguinhos/Fiocruz Collaborate to Enhance Malaria and Dengue Detection in Brazil's National Screening Programs	Sep. 12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

QIAGEN : Markets hailed the Q3 beat + the profitability upgrade

November 07, 2024 at 07:20 am EST